Cargando…
HPR71 Regulatory Journey on Vaccination Against COVID-19 in Brazil
Autores principales: | Arcaro, R, Da Veiga, C, Pereira da Veiga, CR |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232816/ http://dx.doi.org/10.1016/j.jval.2022.04.997 |
Ejemplares similares
-
PIN55 Strategies, Ministers of Health and New Regulations: Did We Win or Were We Won By the COVID-19 Pandemic in Brazil?
por: Arcaro, R., et al.
Publicado: (2021) -
HTA56 COVID-19 from the Perspective of Intellectual Property
por: Pereira da Veiga, CR, et al.
Publicado: (2022) -
HPR171 COVID 19 Vaccination - How to Support Decisions on Vaccination Prioritization for New Variants of Concern?
por: Jahn, B, et al.
Publicado: (2022) -
Infectious salmon anaemia virus (ISAV) in Chilean Atlantic salmon (Salmo salar) aquaculture: emergence of low pathogenic ISAV-HPR0 and re-emergence of virulent ISAV-HPR∆: HPR3 and HPR14
por: Godoy, Marcos G, et al.
Publicado: (2013) -
Journey of the Patient With Melanoma: Understanding Resource Use and Bridging the Gap Between Dermatologist, Surgeon, and Oncologist in Different Health Care Systems
por: Pereira da Veiga, Cássia Rita, et al.
Publicado: (2019)